semaglutide eye sight linked to higher risk of vision problems, FDA data analysis shows Semaglutide Linked to Increased Risk

Patients often face challenges such as emotional eating, which can be a psychological barrier to maintaining weight loss after discontinuing medication

provided methodological support, medical writing, and editorial assistance for manuscript preparation

See all articles Overview Semaglutide and tirzepatide are peptides similar to two hormones produced by the digestive system, namely glucagon-like peptide-1 (GLP-1) and glucosedependent insulinotropic polypeptide (GIP)

Using immobilon chemiluminecent HRP substrate (Millipore, Massachusetts, USA), the protein bands were visualized with the Tanon-5200 Chemiluminescent Imaging System (Tanon, Shanghai, China)